The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Patient Deaths Prompt the FDA to Suspend Three of Merck & Co.'s Keytruda Trials July 5, 2017 6 Blood Testing Startups Hoping to be The Next Theranos – The Good Version January 11, 2018 Stock Soars as Immunomedics CEO, COO Exit and Seattle Genetics Dumps $2 Billion Deal May 4, 2017